Skip to content

Quest Diagnostics DGX Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin132.4%+1.1pp131.3%-2.2pp133.4%-12.7pp146.1%-14.8pp
Operating margin55.9%+2.1pp53.8%+2.9pp50.9%-21.9pp72.9%-21.3pp
Net margin35.8%0.0pp35.7%+1.7pp34.1%-19.1pp53.2%-22.8pp
EBITDA margin76.5%+3.1pp73.4%+3.7pp69.7%-19.6pp89.3%-19.5pp
Free cash flow margin47.2%+7.7pp39.5%+5.5pp34%-23.2pp57.2%-16.4pp
Returns
Return on equity55.2%+2.5pp52.6%+1.3pp51.4%-36.3pp87.7%-44.0pp
Return on assets24.5%+0.6pp23.9%-0.1pp24.1%-17.4pp41.5%-20.0pp
Return on invested capital35.9%+1.6pp34.3%-1.3pp35.7%-21.7pp57.4%-19.8pp
Efficiency
Asset turnover2.7×+0.1×2.7×-0.1×2.8×-0.3×3.1×-0.1×
Inventory turnover153.3×+15.4×137.9×+4.7×133.2×+1.1×132.1×-2.8×
Liquidity
Current ratio4.7×+0.4×4.3×-0.4×4.7×-1.0×5.7×-0.7×
Quick ratio4.3×+0.3×-0.3×4.2×-1.0×5.2×-0.6×
Cash ratio0.7×-0.3×+0.3×0.7×-0.9×1.6×-0.6×
Leverage
Debt-to-equity3.6×0.0×3.6×+0.5×3.2×+0.2×+0.1×
Debt-to-assets1.6×0.0×1.6×+0.1×1.5×+0.1×1.4×0.0×
Net debt / EBITDA12×-0.7×12.8×+1.3×11.4×+4.4×7.1×+2.0×
Valuation
Market capitalization$79.48B+24.1%$64.06B+5.6%$60.67B-5.3%$64.08B-9.7%
Enterprise value$103.86B+20.3%$86.36B+8.7%$79.41B-0.9%$80.13B-6.8%
Price / earnings83.5×+8.1×75.4×-0.4×75.8×+26.1×49.6×+14.9×
Price / sales7.5×+0.7×6.7×+0.3×6.4×+0.2×6.2×-0.4×
Price / book11.1×+1.5×9.6×-0.1×9.7×-0.6×10.3×-0.8×
EV / EBITDA51.1×+1.6×49.5×+1.0×48.4×+13.1×35.4×+6.0×
EV / sales9.8×+0.7×9.1×+0.6×8.4×+0.7×7.8×-0.2×
Free cash flow yield25.3%+1.8pp23.5%+2.5pp21%-16.4pp37.4%-8.3pp
Earnings yield19.2%-2.1pp21.3%+0.1pp21.2%-13.8pp35%-12.0pp
Dividend yield6.9%-1.2pp8.1%0.0pp8.2%+0.5pp7.7%+0.7pp
PEG ratio7.9×-9.5×17.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Quest Diagnostics's profit margins?
Quest Diagnostics (DGX) runs a 33.2% gross margin and a 14.3% operating margin, with a 9.1% net margin.
Where do Quest Diagnostics's ratios come from?
Every ratio is computed from Quest Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.